A Non-interventional Observational Study to Assess Long-term Efficacy and Safety of Dupilumab for the Treatment of Patients (>= 12 Years) With Eosinophilic Esophagitis Under Real-world-conditions in Germany
Abroad (travel likely)Recruiting
Conditions
Eosinophilic Esophagitis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Investigational Site Number: 0000001, Dachau, Bavaria, Germany
Study leads
Clinical Sciences & Operations
Study Director
Sanofi